All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.
Endoscopy, the study or examination of the inside of the body, is a common procedure performed by gastroenterologists inside of the gastrointestinal (GI) tract. It is typically accomplished with long, slender endoscopes, either rigid or flexible.
For typical endoscopy, visualization of the GI tract is significantly enhanced by insufflation, i.e., the release of pressurized gas (air or CO2). Because collapsed tissue inhibits visualization, insufflation is used to expand or distend the GI tract so that it can be fully visualized. Without such inflation, endoscopy moves through only a portion of an often-flattened lumen, failing to image significant parts of the lumen. As a result, incomplete evaluation of the bowel is common when insufflation is not used. Luminal distention is therefore often critical for endoscopy for better visualization, detection, and the efficacy of the entire examination.
However, traditional endoscopy is invasive, usually requires anesthesia, and can be very difficult to move through the small intestine. Recently, there has been commercial success for a distinctly new class of devices known as capsule endoscopes (CE) (including pill cameras, pillcams, wireless capsule endoscopes, or video capsule endoscopes (VCE)). Capsule endoscopies have been revolutionary for gastroenterology, enabling diagnostic procedures that are non-invasive, do not require anesthesia, and provide visualization of anatomies that were previously poorly interrogated, including the small intestine. With capsule endoscopy, manufacturers have gone to great lengths to improve visualization, adding ever-more cameras, side-view cameras, rotating cameras, cameras with a widening field of view, or finer resolution, an increased quantity of more powerful LEDs, faster data transfer rates, and radically higher frame rates. However, none of these improvements are meaningful or helpful if the lumen is flattened and/or covers the lens.
For capsule endoscopy, luminal expansion techniques are currently not available. As such, the procedure's visualization, and thus its entire diagnostic yield and efficacy, is significantly limited.
Studies have been performed with capsule endoscopes that release gas into the gastrointestinal tract for insufflation, and the results show radically improved visualization. Gas release in such studies was accomplished, for example, through the release of pressurized air or as the by-product of a chemical reaction. However, storing and methodically releasing pressurized air aboard a capsule in the gastrointestinal tract is problematic. Excessive localized gas release can cause patient discomfort. Chemical reactions struggle with heat, biocompatibility, foaming and bubbles, longevity, and adequate volume.
Capsule endoscopes including built-in radial extensions have been proposed as a means of making the device more lumen-centric to improve imaging, but these structures do not serve to adequately tent small intestine tissue, as the small intestine tissue is very thin, soft, and compliant and tends to fold over onto the lens of the scope.
A device for use with a capsule endoscope that addresses some or all of these problems is thus desired.
In general, in one embodiment, a device for distending a body lumen for enhanced visualization with a capsule endoscope that includes a camera lens includes an attachment element configured to attach to the capsule endoscope and a plurality of struts extending from the attachment element and meeting at an apex. The plurality of struts are configured to extend both axially and radially away from the camera lens so as to form a frame therearound with the apex positioned a set axial distance away from the camera lens.
This and other embodiments can include one or more of the following features. The attachment element can be an annular ring. The attachment element can be configured to attach to the capsule endoscope through friction fit, adhesive, or clamping. The frame can include a shoulder that is positioned a maximum radial distance away from the capsule scope. The shoulder can be axially offset away from the camera lens. A distance between the shoulder and the apex can be between 10 mm and 30 mm. A diameter of the frame at the shoulder can be between 20 mm and 40 mm. The frame can include a tapered tip. An angle of the taper can be between 30° and 60°. The set axial distance can be between 25 mm and 45 mm. The struts of the plurality of struts can be separated by 30° to 120°. There can be between 4 and 6 struts in the plurality of struts. Each of the plurality of struts can be self-expandable. Each of the plurality of struts can be formed of a shape memory material. The frame can include a biodegradable portion.
In general, in one embodiment, a device for visualization of a body lumen includes a capsule endoscope with a camera lens and a plurality of struts extending from the capsule endoscope and meeting at an apex. The plurality of struts extend both axially and radially away from the camera lens so as to form a frame therearound with the apex positioned a set axial distance away from the camera lens.
This and other embodiments can include one or more of the following features. The frame can include a shoulder that is positioned a maximum radial distance away from the capsule endoscope. The shoulder can be axially offset away from the camera lens. A distance between the shoulder and the apex can be between 10 mm and 30 mm. A diameter of the frame at the shoulder can be between 20 mm and 40 mm. The frame can include a tapered tip. An angle of the taper can be between 30° and 60°. The set axial distance can be between 25 mm and 45 mm. The struts of the plurality of struts can be separated by 30° to 120°. There can be between 4 and 6 struts in the plurality of struts. Each of the plurality of struts can be self-expandable. Each of the plurality of struts can be formed of a shape memory material. The frame can include a biodegradable portion.
In general, in one embodiment, a method of enhancing visualization of a body lumen includes: (1) positioning a device including a capsule endoscope and a plurality of struts attached thereto into a body lumen; (2) expanding the plurality of struts of the device within the body lumen such that the plurality of struts extend both radially and axially away from a camera lens of the capsule endoscope and meet at an apex that is positioned a set axial distance away from the camera lens; and (3) imaging with the camera lens into the body lumen.
This and other embodiments can include one or more of the following features. The plurality of struts can form a frame around the camera lens upon expansion. The frame can include a shoulder that is positioned a maximum radial distance away from the capsule endoscope. The shoulder can be axially offset away from the camera lens. A distance between the shoulder and the apex can be between 10 mm and 30 mm. A diameter of the frame at the shoulder can be between 20 mm and 40 mm. The plurality of struts can form a frame around the camera lens upon expansion. The frame can include a tapered tip. An angle of the taper can be between 30° and 60°. The set axial distance can be between 25 mm and 45 mm. The struts of the plurality of struts can be separated by 30° to 120° upon expansion. There can be between 4 and 6 struts in the plurality of struts. Expanding the plurality of struts can include self-expanding the plurality of struts. Each of the plurality of struts can be formed of a shape memory material. The plurality of struts can form a frame around the camera lens upon expansion. The method can further include dissolving at least a portion of the frame to allow passage of the device from the body.
In general, in one embodiment, a device for distending a body lumen for enhanced visualization with a capsule endoscope that includes a camera lens includes an attachment element configured to attach to the capsule endoscope and a plurality of struts fixed to the attachment element. The plurality of struts are configured to self-expand from a constrained configuration to an expanded configuration in which the plurality of struts extend both axially and radially away from the camera lens so as to form a frame therearound.
This and other embodiments can include one or more of the following features. The struts can be configured to self-expand based upon a trigger within the body lumen. The attachment element can be an annular ring. The attachment element can be configured to attach to the capsule endoscope through friction fit, adhesive, or clamping. The frame can include a tapered tip. An angle of the taper can be between 30° and 60°. The struts of the plurality of struts can be separated by 30° to 120° in the expanded configuration. There can be between 4 and 6 struts in the plurality of struts. Each of the plurality of struts can be formed of a shape memory material. The frame can include a biodegradable portion.
In general, in one embodiment, a device for visualization of a body lumen includes a capsule endoscope with a camera lens and a plurality of struts attached to the capsule endoscope. The plurality of struts are configured to self-expand from a constrained configuration to an expanded configuration in which the plurality of struts extend both axially and radially away from the camera lens so as to form a frame therearound.
This and other embodiments can include one or more of the following features. The device can further include a covering around the struts configured to hold the plurality of struts in the constrained configuration. The covering can be configured to dissolve in the body lumen. The struts can be configured to self-expand based upon a trigger within the body lumen. The frame can include a tapered tip. An angle of the taper can be between 30° and 60°. The struts of the plurality of struts can be separated by 30° to 120° in the expanded configuration. There can be between 4 and 6 struts in the plurality of struts. Each of the plurality of struts can be formed of a shape memory material. The frame can include a biodegradable portion.
In general, in one embodiment, a method of enhancing visualization of a body lumen includes: (1) positioning a device including a capsule endoscope and a plurality of struts attached thereto into a body lumen; (2) self-expanding the plurality of struts of the device within the body lumen from a constrained configuration to an expanded configuration in which the plurality of struts extend both radially and axially away from a camera lens of the capsule endoscope; and (3) imaging with the camera lens through the frame into the body lumen.
This and other embodiments can include one or more of the following features. The frame can include a tapered tip. An angle of the taper can be between 30° and 60°. The struts of the plurality of struts can be separated by 30° to 120° in the expanded configuration. There can be between 4 and 6 struts in the plurality of struts. Each of the plurality of struts can be formed of a shape memory material. The plurality of struts can form a frame around the camera lens in the expanded configuration. The method can further include dissolving at least a portion of the frame to allow passage of the device from the body.
In general, in one embodiment, a device for distending a body lumen for enhanced visualization with a capsule endoscope that includes a camera lens includes an attachment element configured to attach to the capsule endoscope and a plurality of struts fixed to the attachment element. The plurality of struts are configured to extend both axially and radially away from the camera lens so as to form a frame therearound. The frame further includes one or more biodegradable portions.
This and other embodiments can include one or more of the following features. The one or more biodegradable portions can include a node between struts. The plurality of struts can include rounded ends upon biodegradation of the node. The one or more biodegradable portions can include a node within a strut. The frame can include a tapered tip. An angle of the taper can be between 30° and 60°. The struts of the plurality of struts can be separated by 30° to 120°. There can be between 4 and 6 struts in the plurality of struts. Each of the plurality of struts can be self-expandable. Each of the plurality of struts can be formed of a shape memory material. The attachment element can be an annular ring. The attachment element can be configured to attach to the capsule endoscope through friction fit, adhesive, or clamping.
In general, in one embodiment, a device for visualization of a body lumen includes a capsule endoscope with a camera lens and a plurality of struts attached to the capsule endoscope. The plurality of struts are configured to extend both axially and radially away from the camera lens so as to form a frame therearound. The frame further includes one or more biodegradable portions.
This and other embodiments can include one or more of the following features. The one or more biodegradable portions can include a node between struts. Each of the plurality of struts can include rounded ends upon biodegradation of the node. The one or more biodegradable portions can include a node within a strut. The frame can include a tapered tip. An angle of the taper can be between 30° and 60°. The struts of the plurality of struts can be separated by 30° to 120°. There can be between 4 and 6 struts in the plurality of struts. Each of the plurality of struts can be self-expandable. Each of the plurality of struts can be formed of a shape memory material.
In general, in one embodiment, a method of enhancing visualization of a body lumen includes (1) positioning a device including a capsule endoscope and a plurality of struts attached thereto into a body lumen; (2) expanding the plurality of struts of the device within the body lumen such that the plurality of struts extend both radially and axially away from a camera lens of the capsule endoscope to form a frame therearound; (3) imaging with the camera lens through the frame into the body lumen; and (4) dissolving at least a portion of the frame to allow passage of the device from the body lumen.
This and other embodiments can include one or more of the following features. The frame can include a tapered tip. An angle of the taper can be between 30° and 60°. The struts of the plurality of struts can be separated by 30° to 120° upon expansion. There can be between 4 and 6 struts in the plurality of struts. Each of the plurality of struts can be formed of a shape memory material. The method can further include dissolving at least a portion of the frame to allow passage of the device from the body. The portion of the frame can include a node between struts. The plurality of struts can include rounded ends upon biodegradation of the node. The portion of the frame can include a node within a strut.
The novel features of the invention are set forth with particularity in the claims that follow. A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings of which:
Described herein are devices for use with a capsule endoscope (CE) (a pill camera, pillcam, wireless capsule endoscope, or video capsule endoscope (VCE)) that significantly aid in more complete luminal visualization during capsule endoscopy. The devices create local distension of gastrointestinal luminal tissue away from the camera, improving diagnostic yield.
An exemplary luminal expansion device 300 is shown in
A plurality of radiating struts 301 extend from the attachment mechanism 303. The struts 301 emerge from the attachment mechanism 303 (and thus the capsule endoscope 305), extending both axially and radially outward from the camera lens. In other words, the struts 301 are positioned away from the end of the capsule endoscope 305 along the axis 399 (or parallel to the axis 399). The struts 301 also extend radially away from the central axis 399. The struts 301 can each form a shoulder 336 that is radially offset from the camera lens (i.e., to hold tissue away from the sides of the lens of the capsule endoscope 305). The shoulder 336 can be positioned at the maximum radial distance away from the capsule endoscope 305. Further, the shoulder 336 can be axially offset away from the body of the capsule endoscope 305. Further, the struts 301 can meet or cross at an apex 333, i.e., at a point positioned a maximum axial distance away from the lens of the capsule endoscope 305. In one embodiment, and as shown in
In use, the struts 301 can be configured to distend tissue (e.g., within the small intestine) such that luminal folds are unfolded, enabling more complete visualization. The apex 333 can act as the leading edge while the wedge or conical shape of the tip can open tissue up as the device 300 moves through, maintaining an open field of view for the camera of the capsule endoscope 305. The shoulders 336 can help maintain a wide field of view in front of the lens. Moreover, the gaps between the struts 301 can create apertures that allow direct, unobscured tissue viewing. The primarily open structure of the device 300 can further enable the thru-passage of matter, such as chyme, during use.
As shown in
Referring to
The number of struts in each expansion device, and their contacting areas, can vary. For example, the device can include between 3 and 12 struts, such as between 4 and 6 struts, on the distal side and/or the proximal side of the capsule endoscope.
Further, the struts can be spring-like, resilient, or deformable, such that they create an expansive outward force, but are also still flexible enough such that they can be compressed by a sphincter, orifice, or stricture. In some embodiments, for example, the struts can be made of Nitinol wire and can have a diameter, for example, of 0.010 inches to 0.020 inches, such as 0.013 inches or 0.016 inches. In another embodiments, the struts can be made, for example, of a collagen or PEEK suture material and can have a diameter, for example, of 0.020 inches to 0.060 inches, such as 0.030 inches.
In some embodiments, as with devices 300, 400, 500, the shoulder area (335, 436, 536) can extend substantially parallel to the longitudinal axis of the device, thereby creating a non-rounded or flattened portion of each strut. In other embodiments, as shown in
Referring to
Referring to
Further, as shown in
Referring to
In some embodiments, the expansion device can be injection molded, such as an injection-molded polymer (e.g., PEEK, polypropylene, polyethylene, or a high durometer elastomer such as silicone or urethane). For example,
In some embodiments, the device can include a central strut with radiating umbrella-like tip elements.
In some embodiments, the expansion device can have a geometry that enables collapsing for oral entry, as seen in
The covering 2332 can be formed, for example, of polymers used in the pharmaceutical industry that selectively dissolve in the presence of fluids found in different anatomies, including enteric coatings for the delayed release of orally administered medications (Torpac Inc, Fairfield, NJ). Other examples include cellulose acetate phthalate (C-A-P, Eastman Chemicals, Kingsport, TN), Eudragit L 100 and S 100 (Evonik Industries, Darmstadt, Germany), Acryl-ese (Colorcon, West Point, PA), and Surelease (Colorcon). In some embodiments, the material for the covering 2332 can be chosen to dissolve in the colon (e.g., Eudragit S 100) or in the small intestine (e.g., other material listed hereinabove). The polymer dissolution profiles of the chosen material can be engineered from seconds to weeks, depending on the desired imaging location. Further, the covering 2332 can be single-coated, or double, triple, quadruple, or more coatings.
In some embodiments, the expansion devices described herein can have intersections (e.g. strut joints) that are fixed, pivot, hinge, slide, or are unattached in order to aid in collapse.
Once the expansion device it is in the stomach or small intestine, the struts can be expanded. For example, the struts can self-expand due to, e.g., being made of a shape memory material, such as Nitinol.
In some embodiments, expansion can occur once the device is in the small intestine. In other embodiments, expansion can occur once the device is in the stomach or the colon.
Further, expansion can occur, for example, based upon a trigger, including the chemical environment (e.g., pH since the stomach is more acidic than the small intestine), moisture, pressure, temperature, or enzymatic activity, time, location, or visual clues (e.g., the camera can recognize villi, which only occur in the small intestine). In other embodiments, expansion can occur, for example, based upon a dissolution mechanism (such as dissolution of the covering described above) or micro-actuators that are electrically triggered (including the use of micro motors, reed switches, magnetic actuators, piezo actuators, nitinol heated by a battery, or a membrane heated by a battery to release gas, chemicals, or mechanical motion).
Referring to
As shown in
As shown in
In some embodiments, the struts can be pre-shaped such that they coil or otherwise shrink into smaller shapes once they have been separated at biodegradable joints.
In some embodiments, the expansion device can have components with different dissolution rates. In one example, there can be sub-element struts that decompose slowly (e.g. over days or weeks) coupled by fusible nodes that decompose more rapidly (e.g., within 24 hours). An exemplary chart of dissolution of structures is shown in
In some embodiments, the entire structure of the struts can decompose.
Dissolution of all or portions of the devices described herein can aid in passage through the body.
In some embodiments, the struts or other surfaces of the devices described herein can have surface features incorporated thereon. For example, the struts can have coatings that create either enhanced or lowered frictional values. The surface features in some embodiments can be very small external protrusions or scales to create a retarding or grabbing effect.
The expansion devices described herein can be comprised of a material that does not readily corrode. The material can be elastic or superelastic (e.g., nitinol). The material can be, for example, a hydrocarbon or a plastic, such as nylon, polycarbonate, or polyethylene, or an elastomer, including a silicone, urethane, or pebax. The struts and other structures of the devices described herein can be heat set, molded, cast, adhered, or otherwise formed.
In some embodiments, the devices described herein can be covered with one or more sheets, including clear sheets. The sheets can be treated so that they readily repel or attract wet tissue.
In some embodiments, parts of the expansion devices described herein can be infused with radio-opaque materials to aid in fluoroscopy visualization.
In some embodiments, the luminal expansion devices described herein can be symmetrical (i.e., can be created through an axis of rotation). In other embodiments, the devices can be asymmetric.
In some embodiments, the leading edge or apex of the expansion device can be tapered, bullet-nosed, conical, or rounded.
The struts of the devices described herein can have a circular, oval, square, rectangular, or other cross section.
The struts of the devices described herein can be monolithic, i.e., made of a single material. In other embodiments, the struts can be composite structures, such as be made of tubes with an outer layer (with its own properties and materials) and an inner portion (with its own properties and materials). In one embodiment, the struts can be small tubes that are inflated with a pressurized fluid or gas.
In some embodiments, referring to
The expansion devices described herein can attach to the housing of the capsule endoscope or to the optical hood of the capsule endoscope. In some embodiments, the expansion device can be designed as an integral part of the capsule endoscope.
Referring to
Further, referring to
Alternatively, in some embodiments, the expansion device (and capsule endoscope) can be directly placed into the stomach with an ancillary device.
The expansion devices described herein can advantageously improve the field of view when used with a capsule endoscope.
As shown in
Any of the features or elements of any of the expansion devices described herein may be combined or substituted for features or elements of any other expansion device.
Additional details pertinent to the present invention, including materials and manufacturing techniques, may be employed as within the level of those with skill in the relevant art. The same may hold true with respect to method-based aspects of the invention in terms of additional acts commonly or logically employed. Also, it is contemplated that any optional feature of the inventive variations described may be set forth and claimed independently, or in combination with any one or more of the features described herein. Likewise, reference to a singular item, includes the possibility that there are a plurality of the same items present. More specifically, as used herein and in the appended claims, the singular forms “a,” “and,” “said,” and “the” include plural referents unless the context clearly dictates otherwise. It is further noted that the claims may be drafted to exclude any optional element. As such, this statement is intended to serve as antecedent basis for use of such exclusive terminology as “solely,” “only” and the like in connection with the recitation of claim elements, or use of a “negative” limitation. Unless defined otherwise herein, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. The breadth of the present invention is not to be limited by the subject specification, but rather only by the plain meaning of the claim terms employed.
When a feature or element is herein referred to as being “on” another feature or element, it can be directly on the other feature or element or intervening features and/or elements may also be present. In contrast, when a feature or element is referred to as being “directly on” another feature or element, there are no intervening features or elements present. It will also be understood that, when a feature or element is referred to as being “connected”, “attached” or “coupled” to another feature or element, it can be directly connected, attached or coupled to the other feature or element or intervening features or elements may be present. In contrast, when a feature or element is referred to as being “directly connected”, “directly attached” or “directly coupled” to another feature or element, there are no intervening features or elements present. Although described or shown with respect to one embodiment, the features and elements so described or shown can apply to other embodiments. It will also be appreciated by those of skill in the art that references to a structure or feature that is disposed “adjacent” another feature may have portions that overlap or underlie the adjacent feature.
Terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. For example, as used herein, the singular forms “a”, “an” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise. It will be further understood that the terms “comprises” and/or “comprising,” when used in this specification, specify the presence of stated features, steps, operations, elements, and/or components, but do not preclude the presence or addition of one or more other features, steps, operations, elements, components, and/or groups thereof. As used herein, the term “and/or” includes any and all combinations of one or more of the associated listed items and may be abbreviated as “/”.
Spatially relative terms, such as “under”, “below”, “lower”, “over”, “upper” and the like, may be used herein for ease of description to describe one element or feature's relationship to another element(s) or feature(s) as illustrated in the figures. It will be understood that the spatially relative terms are intended to encompass different orientations of the device in use or operation in addition to the orientation depicted in the figures. For example, if a device in the figures is inverted, elements described as “under” or “beneath” other elements or features would then be oriented “over” the other elements or features. Thus, the exemplary term “under” can encompass both an orientation of over and under. The device may be otherwise oriented (rotated 90 degrees or at other orientations) and the spatially relative descriptors used herein interpreted accordingly. Similarly, the terms “upwardly”, “downwardly”, “vertical”, “horizontal” and the like are used herein for the purpose of explanation only unless specifically indicated otherwise.
Although the terms “first” and “second” may be used herein to describe various features/elements, these features/elements should not be limited by these terms, unless the context indicates otherwise. These terms may be used to distinguish one feature/element from another feature/element. Thus, a first feature/element discussed below can be termed a second feature/element, and similarly, a second feature/element discussed below can be termed a first feature/element without departing from the teachings of the present invention.
As used herein in the specification and claims, including as used in the examples and unless otherwise expressly specified, all numbers may be read as if prefaced by the word “about” or “approximately,” even if the term does not expressly appear. The phrase “about” or “approximately” may be used when describing magnitude and/or position to indicate that the value and/or position described is within a reasonable expected range of values and/or positions. For example, a numeric value may have a value that is +/−0.1% of the stated value (or range of values), +/−1% of the stated value (or range of values), +/−2% of the stated value (or range of values), +/−5% of the stated value (or range of values), +/−10% of the stated value (or range of values), etc. Any numerical range recited herein is intended to include all sub-ranges subsumed therein.
This application is a continuation of U.S. application Ser. No. 16/325,497, filed Feb. 14, 2019, which is a 371 of International Application No. PCT/US2017/047591, International Filing Date Aug. 18, 2017, which claims the benefit of U.S. Provisional Patent Application No. 62/376,816, filed Aug. 18, 2016 and titled “DEVICE AND METHOD FOR ENHANCED VISUALIZATION OF THE SMALL INTESTINE,” the entirety of which is incorporated by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
2268321 | Flynn | Dec 1941 | A |
2767705 | Moore | Oct 1956 | A |
3859986 | Okada et al. | Jan 1975 | A |
3998216 | Hosono | Dec 1976 | A |
4066071 | Nagel | Jan 1978 | A |
4141364 | Schultze | Feb 1979 | A |
4151800 | Dotts et al. | May 1979 | A |
4176662 | Frazer | Dec 1979 | A |
4425919 | Alston, Jr. | Jan 1984 | A |
4551140 | Shinohara | Nov 1985 | A |
4690131 | Lyddy, Jr. et al. | Sep 1987 | A |
4696544 | Costella | Sep 1987 | A |
4717379 | Ekholmer | Jan 1988 | A |
4794412 | Casey et al. | Dec 1988 | A |
4794912 | Lia | Jan 1989 | A |
4815450 | Patel | Mar 1989 | A |
4817613 | Jaraczewski et al. | Apr 1989 | A |
4893613 | Hake | Jan 1990 | A |
4913369 | Lia et al. | Apr 1990 | A |
4959058 | Michelson | Sep 1990 | A |
4961738 | Mackin | Oct 1990 | A |
5018436 | Evangelista et al. | May 1991 | A |
5019121 | Krauter | May 1991 | A |
5037386 | Marcus et al. | Aug 1991 | A |
5105819 | Wollschlager et al. | Apr 1992 | A |
5123421 | Sinofsky | Jun 1992 | A |
5125143 | Takahashi | Jun 1992 | A |
5174276 | Crockard | Dec 1992 | A |
5188595 | Jacobi | Feb 1993 | A |
5201908 | Jones | Apr 1993 | A |
5251611 | Zehel et al. | Oct 1993 | A |
5337733 | Bauerfeind et al. | Aug 1994 | A |
5360440 | Andersen | Nov 1994 | A |
5496292 | Burnham | Mar 1996 | A |
5531685 | Hemmer et al. | Jul 1996 | A |
5531719 | Takahashi | Jul 1996 | A |
5577992 | Chiba et al. | Nov 1996 | A |
5601588 | Tonomura et al. | Feb 1997 | A |
5603991 | Kupiecki et al. | Feb 1997 | A |
5607435 | Sachdeva et al. | Mar 1997 | A |
5624381 | Kieturakis | Apr 1997 | A |
5632734 | Galel et al. | May 1997 | A |
5662587 | Grundfest et al. | Sep 1997 | A |
5662621 | Lafontaine | Sep 1997 | A |
5746692 | Bacich et al. | May 1998 | A |
5749828 | Solomon et al. | May 1998 | A |
5759151 | Sturges | Jun 1998 | A |
5779624 | Chang | Jul 1998 | A |
5782811 | Samson et al. | Jul 1998 | A |
5823961 | Fields et al. | Oct 1998 | A |
5882347 | Laan et al. | Mar 1999 | A |
5891112 | Samson | Apr 1999 | A |
5891114 | Chin et al. | Apr 1999 | A |
5906591 | Dario et al. | May 1999 | A |
5916145 | Chu et al. | Jun 1999 | A |
5916147 | Boury | Jun 1999 | A |
5951539 | Nita et al. | Sep 1999 | A |
5976074 | Moriyama | Nov 1999 | A |
6090099 | Samson et al. | Jul 2000 | A |
6159187 | Park et al. | Dec 2000 | A |
6162171 | Ng et al. | Dec 2000 | A |
6179776 | Adams et al. | Jan 2001 | B1 |
6190357 | Ferrari et al. | Feb 2001 | B1 |
6217565 | Cohen | Apr 2001 | B1 |
6296644 | Surat et al. | Oct 2001 | B1 |
6309346 | Farhadi | Oct 2001 | B1 |
6352503 | Matsu et al. | Mar 2002 | B1 |
6364878 | Hall | Apr 2002 | B1 |
6368315 | Gillis et al. | Apr 2002 | B1 |
6468203 | Belson | Oct 2002 | B2 |
6485409 | Voloshin et al. | Nov 2002 | B1 |
6503225 | Kirsch et al. | Jan 2003 | B1 |
6517477 | Wendlandt | Feb 2003 | B1 |
6547724 | Soble et al. | Apr 2003 | B1 |
6572538 | Takase | Jun 2003 | B2 |
6572590 | Stevens et al. | Jun 2003 | B1 |
6579277 | Rabiner et al. | Jun 2003 | B1 |
6610007 | Belson et al. | Aug 2003 | B2 |
6612982 | Ouchi | Sep 2003 | B1 |
6616628 | Hayzelden | Sep 2003 | B2 |
6620126 | Unsworth et al. | Sep 2003 | B2 |
6623424 | Hayakawa et al. | Sep 2003 | B2 |
6712832 | Shah | Mar 2004 | B2 |
6726677 | Flaherty et al. | Apr 2004 | B1 |
6730020 | Peng et al. | May 2004 | B2 |
6780151 | Grabover et al. | Aug 2004 | B2 |
6783491 | Saadat et al. | Aug 2004 | B2 |
6790173 | Saadat et al. | Sep 2004 | B2 |
6793621 | Butler et al. | Sep 2004 | B2 |
6793661 | Hamilton et al. | Sep 2004 | B2 |
6800056 | Tartaglia et al. | Oct 2004 | B2 |
6869393 | Butler | Mar 2005 | B2 |
6899673 | Ogura et al. | May 2005 | B2 |
6911004 | Kim et al. | Jun 2005 | B2 |
6923754 | Lubock | Aug 2005 | B2 |
6960162 | Saadat et al. | Nov 2005 | B2 |
6974411 | Belson | Dec 2005 | B2 |
6984203 | Tartaglia et al. | Jan 2006 | B2 |
7060199 | Woydt et al. | Jun 2006 | B2 |
7172552 | Wendlandt | Feb 2007 | B2 |
7214230 | Brock et al. | May 2007 | B2 |
7288101 | Deem et al. | Oct 2007 | B2 |
7291127 | Eidenschink | Nov 2007 | B2 |
7365509 | Park et al. | Apr 2008 | B2 |
7438712 | Chouinard | Oct 2008 | B2 |
7511733 | Takizawa et al. | Mar 2009 | B2 |
7537562 | Takano | May 2009 | B2 |
7559916 | Smith et al. | Jul 2009 | B2 |
7591782 | Fujikura | Sep 2009 | B2 |
7598652 | Kombluh et al. | Oct 2009 | B2 |
7695428 | Machida | Apr 2010 | B2 |
7736323 | Von Weymarn-Scharli | Jun 2010 | B2 |
7749196 | Osborne et al. | Jul 2010 | B2 |
7837615 | Le et al. | Nov 2010 | B2 |
7850725 | Vardi et al. | Dec 2010 | B2 |
7901347 | Sekiguchi et al. | Mar 2011 | B2 |
7909755 | Itoi | Mar 2011 | B2 |
7918819 | Karmarkar et al. | Apr 2011 | B2 |
7918845 | Saadat et al. | Apr 2011 | B2 |
7931661 | Saadat et al. | Apr 2011 | B2 |
7935047 | Yoshida et al. | May 2011 | B2 |
7947000 | Vargas et al. | May 2011 | B2 |
7957790 | Kleen | Jun 2011 | B2 |
7970455 | Zilberstein et al. | Jun 2011 | B2 |
7988621 | Smith et al. | Aug 2011 | B2 |
8047236 | Perry | Nov 2011 | B2 |
8075476 | Vargas | Dec 2011 | B2 |
8092374 | Smith et al. | Jan 2012 | B2 |
8109953 | King, III et al. | Feb 2012 | B1 |
8123739 | McQueen et al. | Feb 2012 | B2 |
8125755 | Garcia et al. | Feb 2012 | B2 |
8192422 | Zubiate et al. | Jun 2012 | B2 |
8206287 | Matsuo | Jun 2012 | B2 |
8226548 | Kucklick | Jul 2012 | B2 |
8241299 | Hibner | Aug 2012 | B2 |
8246575 | Viola | Aug 2012 | B2 |
8257257 | Takizawa et al. | Sep 2012 | B2 |
8298161 | Vargas | Oct 2012 | B2 |
8313014 | Bettuchi | Nov 2012 | B2 |
8361090 | Belson | Jan 2013 | B2 |
8366606 | Watanabe et al. | Feb 2013 | B2 |
8388519 | Garcia et al. | Mar 2013 | B2 |
8439825 | Sekiguchi | May 2013 | B2 |
8460179 | Ikeda et al. | Jun 2013 | B2 |
8485968 | Weimer et al. | Jul 2013 | B2 |
8496648 | Rogers | Jul 2013 | B2 |
8506479 | Piskun et al. | Aug 2013 | B2 |
8517923 | Belson et al. | Aug 2013 | B2 |
8545491 | Abboud et al. | Oct 2013 | B2 |
8550989 | Dohi et al. | Oct 2013 | B2 |
8556804 | Smith et al. | Oct 2013 | B2 |
8663096 | Viola | Mar 2014 | B2 |
8663196 | Kassab et al. | Mar 2014 | B2 |
8708894 | Smith et al. | Apr 2014 | B2 |
8721530 | Ohline et al. | May 2014 | B2 |
8753312 | Bowe et al. | Jun 2014 | B2 |
8777844 | Sadanand | Jul 2014 | B1 |
8920369 | Salahieh et al. | Dec 2014 | B2 |
8969639 | Xu et al. | Mar 2015 | B2 |
9011318 | Choset et al. | Apr 2015 | B2 |
9066655 | Stefanchik et al. | Jun 2015 | B2 |
9114228 | Zook et al. | Aug 2015 | B2 |
9125653 | Kovach | Sep 2015 | B2 |
9155451 | Smith et al. | Oct 2015 | B2 |
9192284 | Hirsch et al. | Nov 2015 | B2 |
9192288 | Okaniwa | Nov 2015 | B2 |
9211140 | Lauryssen et al. | Dec 2015 | B2 |
9220398 | Woodley et al. | Dec 2015 | B2 |
9226825 | Starksen et al. | Jan 2016 | B2 |
9241611 | Konno | Jan 2016 | B2 |
9254123 | Alvarez et al. | Feb 2016 | B2 |
9295511 | Smith et al. | Mar 2016 | B2 |
9358073 | Piligian et al. | Jun 2016 | B2 |
9364955 | Oyola et al. | Jun 2016 | B2 |
9386910 | West | Jul 2016 | B2 |
9498108 | Lombardi | Nov 2016 | B1 |
9498198 | Hu et al. | Nov 2016 | B2 |
9505125 | Zubiate et al. | Nov 2016 | B2 |
9585546 | Surti et al. | Mar 2017 | B2 |
9610068 | Kappel et al. | Apr 2017 | B2 |
9649473 | Gregorich et al. | May 2017 | B2 |
9763562 | Avitsian et al. | Sep 2017 | B2 |
9814372 | Smith et al. | Nov 2017 | B2 |
9913570 | Kucharski et al. | Mar 2018 | B2 |
9937324 | Kim et al. | Apr 2018 | B2 |
9993142 | Salman et al. | Jun 2018 | B2 |
10092291 | Voegele et al. | Oct 2018 | B2 |
10307042 | Lombardi | Jun 2019 | B2 |
10463495 | Rogers et al. | Nov 2019 | B2 |
11122971 | Tilson | Sep 2021 | B2 |
11135398 | Tilson et al. | Oct 2021 | B2 |
11554248 | Tilson et al. | Jan 2023 | B1 |
20010041881 | Sarge et al. | Nov 2001 | A1 |
20020107478 | Wendlandt | Aug 2002 | A1 |
20020161355 | Wollschlager | Oct 2002 | A1 |
20030023259 | Dubrul et al. | Jan 2003 | A1 |
20030035048 | Shipp | Feb 2003 | A1 |
20030083546 | Butler et al. | May 2003 | A1 |
20030122374 | Ouchi et al. | Jul 2003 | A1 |
20030153866 | Long et al. | Aug 2003 | A1 |
20030208220 | Worley et al. | Nov 2003 | A1 |
20030216622 | Meron | Nov 2003 | A1 |
20030216691 | Jacobson | Nov 2003 | A1 |
20030225379 | Schaffer et al. | Dec 2003 | A1 |
20040019252 | Hirata | Jan 2004 | A1 |
20040044350 | Martin et al. | Mar 2004 | A1 |
20040092960 | Abrams et al. | May 2004 | A1 |
20040176664 | Iddan | Sep 2004 | A1 |
20040186349 | Ewers et al. | Sep 2004 | A1 |
20040186350 | Brenneman et al. | Sep 2004 | A1 |
20040242958 | Fujikawa et al. | Dec 2004 | A1 |
20040243227 | Starksen et al. | Dec 2004 | A1 |
20040260236 | Manning et al. | Dec 2004 | A1 |
20050005363 | Giori et al. | Jan 2005 | A1 |
20050010237 | Niazi | Jan 2005 | A1 |
20050085829 | Kraemer et al. | Apr 2005 | A1 |
20050165275 | Von Felten et al. | Jul 2005 | A1 |
20050203340 | Butler et al. | Sep 2005 | A1 |
20050272974 | Iddan | Dec 2005 | A1 |
20050277966 | Ewers et al. | Dec 2005 | A1 |
20060041188 | Dirusso et al. | Feb 2006 | A1 |
20060047183 | Park | Mar 2006 | A1 |
20060058582 | Maahs et al. | Mar 2006 | A1 |
20060129130 | Tal et al. | Jun 2006 | A1 |
20060192465 | Kombluh et al. | Aug 2006 | A1 |
20060258906 | Binmoeller | Nov 2006 | A1 |
20060264707 | Kinney | Nov 2006 | A1 |
20060264821 | Vo et al. | Nov 2006 | A1 |
20060287666 | Saadat et al. | Dec 2006 | A1 |
20070015965 | Cox et al. | Jan 2007 | A1 |
20070038025 | Yoshida | Feb 2007 | A1 |
20070045504 | Wollschlager | Mar 2007 | A1 |
20070088367 | Von Weymarn-Scharli | Apr 2007 | A1 |
20070100414 | Licata et al. | May 2007 | A1 |
20070106302 | Ortiz | May 2007 | A1 |
20070118015 | Wendlandt | May 2007 | A1 |
20070156018 | Krauter et al. | Jul 2007 | A1 |
20070161851 | Takizawa | Jul 2007 | A1 |
20070219411 | Dejima et al. | Sep 2007 | A1 |
20070239252 | Hopkins et al. | Oct 2007 | A1 |
20070250149 | Oepen et al. | Oct 2007 | A1 |
20070260121 | Bakos et al. | Nov 2007 | A1 |
20080051635 | Tanaka et al. | Feb 2008 | A1 |
20080058722 | Oepen et al. | Mar 2008 | A1 |
20080091073 | Park | Apr 2008 | A1 |
20080103440 | Ferren et al. | May 2008 | A1 |
20080139887 | Fitzpatrick | Jun 2008 | A1 |
20080172037 | Huang et al. | Jul 2008 | A1 |
20080188928 | Salahieh et al. | Aug 2008 | A1 |
20080200762 | Stokes et al. | Aug 2008 | A1 |
20080214893 | Tartaglia et al. | Sep 2008 | A1 |
20080234546 | Kawano et al. | Sep 2008 | A1 |
20080242928 | Kawano et al. | Oct 2008 | A1 |
20080249362 | Jiang et al. | Oct 2008 | A1 |
20080262300 | Ewers et al. | Oct 2008 | A1 |
20080275299 | Park | Nov 2008 | A1 |
20090023983 | Stefanchik | Jan 2009 | A1 |
20090048483 | Yamamoto | Feb 2009 | A1 |
20090062611 | Toyama | Mar 2009 | A1 |
20090062837 | Gasche et al. | Mar 2009 | A1 |
20090112063 | Bakos et al. | Apr 2009 | A1 |
20090131752 | Park | May 2009 | A1 |
20090157068 | Kallel et al. | Jun 2009 | A1 |
20090187163 | Uihlein | Jul 2009 | A1 |
20090240202 | Drasler et al. | Sep 2009 | A1 |
20090259200 | Lampropoulos et al. | Oct 2009 | A1 |
20090264704 | Shtul | Oct 2009 | A1 |
20100010308 | Braun et al. | Jan 2010 | A1 |
20100010437 | Miles et al. | Jan 2010 | A1 |
20100016663 | Maisch et al. | Jan 2010 | A1 |
20100036363 | Watanabe et al. | Feb 2010 | A1 |
20100069712 | Yamaya | Mar 2010 | A1 |
20100069716 | Chin et al. | Mar 2010 | A1 |
20100076451 | Zwolinski et al. | Mar 2010 | A1 |
20100087711 | Edwards | Apr 2010 | A1 |
20100137686 | Meron et al. | Jun 2010 | A1 |
20100145151 | Fukunaga et al. | Jun 2010 | A1 |
20100160735 | Bakos | Jun 2010 | A1 |
20100204546 | Hassidov et al. | Aug 2010 | A1 |
20100268025 | Belson | Oct 2010 | A1 |
20100331625 | Rosemurgy et al. | Dec 2010 | A1 |
20100331820 | Prisco et al. | Dec 2010 | A1 |
20110015729 | Jimenez et al. | Jan 2011 | A1 |
20110023888 | Vazales et al. | Feb 2011 | A1 |
20110040282 | Uihlein | Feb 2011 | A1 |
20110046442 | Matsushita | Feb 2011 | A1 |
20110049282 | Danielsson | Mar 2011 | A1 |
20110054253 | Jordá Albiñana et al. | Mar 2011 | A1 |
20110087070 | Tilson et al. | Apr 2011 | A1 |
20110237888 | Matsushita | Sep 2011 | A1 |
20110245611 | Yeh et al. | Oct 2011 | A1 |
20110282149 | Vargas et al. | Nov 2011 | A1 |
20110301414 | Hotto et al. | Dec 2011 | A1 |
20110306950 | Cucin | Dec 2011 | A1 |
20110319714 | Roelle et al. | Dec 2011 | A1 |
20120022329 | Wagh et al. | Jan 2012 | A1 |
20120041291 | Ferren et al. | Feb 2012 | A1 |
20120095548 | Gregorich et al. | Apr 2012 | A1 |
20120108902 | Frassica et al. | May 2012 | A1 |
20120130173 | Lutze et al. | May 2012 | A1 |
20120143005 | Yeh et al. | Jun 2012 | A1 |
20120165607 | Ashida et al. | Jun 2012 | A1 |
20120165792 | Ortiz et al. | Jun 2012 | A1 |
20120172651 | Cutrer | Jul 2012 | A1 |
20120209062 | Qiao | Aug 2012 | A1 |
20120277528 | Qiao | Nov 2012 | A1 |
20120277729 | Melsheimer | Nov 2012 | A1 |
20130131641 | Jimenez et al. | May 2013 | A1 |
20130190565 | Gora et al. | Jul 2013 | A1 |
20130338440 | Sinal et al. | Dec 2013 | A1 |
20140005683 | Stand et al. | Jan 2014 | A1 |
20140073853 | Swisher et al. | Mar 2014 | A1 |
20140081169 | Gerding et al. | Mar 2014 | A1 |
20140088459 | Roush et al. | Mar 2014 | A1 |
20140142393 | Piskun et al. | May 2014 | A1 |
20140155702 | Tilson et al. | Jun 2014 | A1 |
20140155783 | Starksen et al. | Jun 2014 | A1 |
20140188054 | Iijima et al. | Jul 2014 | A1 |
20140234600 | Wang et al. | Aug 2014 | A1 |
20140243873 | Franklin | Aug 2014 | A1 |
20140275860 | Rottenberg et al. | Sep 2014 | A1 |
20140276601 | Edward | Sep 2014 | A1 |
20140276642 | Cully et al. | Sep 2014 | A1 |
20140343358 | Hameed et al. | Nov 2014 | A1 |
20140371764 | Oyola et al. | Dec 2014 | A1 |
20150018616 | Kumoyama | Jan 2015 | A1 |
20150038919 | Bramwell et al. | Feb 2015 | A1 |
20150073216 | Papay | Mar 2015 | A1 |
20150073409 | Watson et al. | Mar 2015 | A1 |
20150094656 | Salahieh et al. | Apr 2015 | A1 |
20150119640 | Reydel | Apr 2015 | A1 |
20150126814 | Mesallum et al. | May 2015 | A1 |
20150133729 | Reydel | May 2015 | A1 |
20150148602 | Hill et al. | May 2015 | A1 |
20150148606 | Rottenberg et al. | May 2015 | A1 |
20150164314 | Peterson | Jun 2015 | A1 |
20150216589 | Wittenberger et al. | Aug 2015 | A1 |
20150342608 | Hernandez | Dec 2015 | A1 |
20150369325 | Bureau et al. | Dec 2015 | A1 |
20160007832 | Shimada | Jan 2016 | A1 |
20160066773 | Cooper et al. | Mar 2016 | A1 |
20160096004 | Gerrans et al. | Apr 2016 | A1 |
20160129547 | Duescher et al. | May 2016 | A1 |
20160136393 | Tsai et al. | May 2016 | A1 |
20160174829 | Reydel | Jun 2016 | A1 |
20160198935 | Choi et al. | Jul 2016 | A1 |
20160270870 | Kowshik | Sep 2016 | A1 |
20160287059 | Ha et al. | Oct 2016 | A1 |
20160324412 | Hassidov et al. | Nov 2016 | A1 |
20170156567 | Kaneko | Jun 2017 | A1 |
20170157363 | Barrish et al. | Jun 2017 | A1 |
20170340862 | Calabrese et al. | Nov 2017 | A1 |
20170360281 | Ponsky | Dec 2017 | A1 |
20180015257 | Krolik et al. | Jan 2018 | A1 |
20180064366 | Sweeney et al. | Mar 2018 | A1 |
20180132705 | Higuchi | May 2018 | A1 |
20180184885 | St. George | Jul 2018 | A1 |
20180249893 | Yeung et al. | Sep 2018 | A1 |
20180263469 | Okaniwa et al. | Sep 2018 | A1 |
20180264239 | Piskun | Sep 2018 | A1 |
20180271354 | Tilson et al. | Sep 2018 | A1 |
20180289925 | Palmer et al. | Oct 2018 | A1 |
20180326197 | McArthur et al. | Nov 2018 | A1 |
20180361116 | Quick et al. | Dec 2018 | A1 |
20180374603 | Greenwood | Dec 2018 | A1 |
20200100653 | Nakamura | Apr 2020 | A1 |
20200171276 | Onozuka | Jun 2020 | A1 |
20200178763 | Tilson et al. | Jun 2020 | A1 |
20200315433 | Axon et al. | Oct 2020 | A1 |
20200383677 | Piligian et al. | Dec 2020 | A1 |
20210030260 | Julian et al. | Feb 2021 | A1 |
20210137366 | Tilson et al. | May 2021 | A1 |
20230001134 | Tilson et al. | Jan 2023 | A1 |
20230014281 | Tilson et al. | Jan 2023 | A1 |
20230338702 | Tilson et al. | Oct 2023 | A1 |
Number | Date | Country |
---|---|---|
2013207571 | Aug 2013 | AU |
2613655 | Apr 2004 | CN |
1706349 | Dec 2005 | CN |
1732855 | Feb 2006 | CN |
1806770 | Jul 2006 | CN |
1861011 | Nov 2006 | CN |
101119765 | Feb 2008 | CN |
101129255 | Feb 2008 | CN |
101888872 | Nov 2010 | CN |
102137628 | Jul 2011 | CN |
201899767 | Jul 2011 | CN |
102711585 | Oct 2012 | CN |
102872519 | Jan 2013 | CN |
103384500 | Nov 2013 | CN |
104168860 | Nov 2014 | CN |
104287684 | Mar 2016 | CN |
105759418 | Jul 2016 | CN |
105832279 | Aug 2016 | CN |
106137397 | Nov 2016 | CN |
106455929 | Feb 2017 | CN |
106488744 | Mar 2017 | CN |
106659367 | May 2017 | CN |
107296584 | Oct 2017 | CN |
102005039601 | Feb 2007 | DE |
401129 | Dec 1990 | EP |
0941743 | Sep 1999 | EP |
1662972 | Jun 2006 | EP |
1695657 | Aug 2006 | EP |
1487318 | Mar 2008 | EP |
2016914 | Jan 2009 | EP |
1499227 | Oct 2010 | EP |
2258322 | Dec 2010 | EP |
2364637 | Sep 2011 | EP |
2368481 | Sep 2011 | EP |
2368483 | Sep 2011 | EP |
3256052 | Dec 2017 | EP |
2604175 | Nov 2019 | EP |
2482355 | Oct 2010 | GB |
2497544 | Jun 2013 | GB |
H05293077 | Nov 1993 | JP |
2002125921 | May 2002 | JP |
2005152300 | Jun 2005 | JP |
2005323778 | Nov 2005 | JP |
03965108 | Aug 2007 | JP |
2009507617 | Feb 2009 | JP |
2009061173 | Mar 2009 | JP |
2011194126 | Oct 2011 | JP |
2013176465 | Sep 2013 | JP |
2014124475 | Jul 2014 | JP |
10-2015-0131502 | Nov 2015 | KR |
20180053852 | May 2018 | KR |
WO9743941 | Nov 1997 | WO |
WO99053827 | Oct 1999 | WO |
WO03013348 | Feb 2003 | WO |
WO2007035931 | Mar 2007 | WO |
WO2008041809 | Apr 2008 | WO |
WO2008122969 | Oct 2008 | WO |
WO2008122997 | Oct 2008 | WO |
WO2009154192 | Dec 2009 | WO |
WO2011018147 | Feb 2011 | WO |
WO2011018157 | Feb 2011 | WO |
WO2011148172 | Dec 2011 | WO |
WO2012054480 | Apr 2012 | WO |
WO2012080947 | Jun 2012 | WO |
WO2012122288 | Sep 2012 | WO |
WO2016034598 | Mar 2016 | WO |
WO2017041052 | Mar 2017 | WO |
WO2018035452 | Aug 2017 | WO |
Entry |
---|
Entrada@ colonic overtube product brochure downloaded from internet http://www.usendoscopy.com/˜/media/Files/Documents/Spec-Sheet-International/760358c_entrada_intl_ss_web.pdf Accessed Date: Jun. 5, 2017 (year of pub sufficiently earlier than effective US filing date and any foreign priority date) 2009. |
Filip et al.; Design, Implementation, and Testing of a miniature self-stabilizing capsule endoscope with wireless image transmission capabilities; Int. Joumal “information Technologies & Knowledge”; 5(1); downloaded from http://www.foibg.com/ijilk/ijilk-vol05/ijitk05-1-p01.pdf on Jul. 28, 2016, (year of pub sufficiently earlier than effective US filing date and any foreign priority date) 2011. |
Loeve et al.; Endoscope Shaft-Rigidity Control Mechanism: “Forguide”; IEEE Trans. on Biomed. Eng.; 59(2); pp. 542-551; Feb. 2012. |
Loeve et al.; Vacuum packed particles as flexible endoscope guides with controllable rigidity; Granular Matter; 12(6); pp. 543-554; Jun. 24, 2010. |
Shah et al.; Magnetic Imaging of Colonoscopy: An Audit of Looping, Accuracy and Ancillary maneuvers; Gastrointest. Endosc.; 52(1); pp. 1-8; Jul. 1, 2000. |
Simi et al.; Design, Fabrication, and Testing of a Capsule With Hybrid Locomotion for Gastrointestinal Tract Exploration; IEEE/ASME Trans on Mechatronics; 15(2); pp. 170-x; Apr. 2010. |
Valdastri et al.; Advanced Technologies for Gastrointestinal Endoscopy; Annu. Rev. Biomed. Eng.; 14; pp. 397-429; May 2012. |
Zhao et al.; Development of a variable stiffness over tube based on low-melting-point-alloy for endoscopic surgery; J. Med. Devices; 10(2); 8 pages; May 12, 2016. |
Tilson et al.; U.S. Appl. No. 17/493,785 entitled “Dynamically rigidizing composite medical structures,” filed Oct. 4, 2021. |
Tilson et al.; U.S. Appl. No. 17/644,758 entitled “Device for endoscopic advancement through the small intestine,” filed Dec. 16, 2021. |
Tilson et al.; U.S. Appl. No. 17/604,203 entitled “Dynamically rigidizing composite medical structures,” filed Oct. 15, 2021. |
Dow, Dow white paper: Can you estimate modulus from durometer hardness for silicones: Yes, but you only roughly and you must choose your modulus carefully!; 5 pages; retrieved from the internet (https://www.dow.com/content/dam/doc/documents/en-us/tech-art/11/11-37/11-3716-01-durometer-hardness-for-silicones.pdf) on Jan. 18, 2023. |
Lopez et al.; U.S. Appl. No. 17/995,294 entitled “Layered walls for rigidizing devices,” filed Sep. 30, 2022. |
Scheeff et al.; U.S. Appl. No. 18/000,062 entitled “Rigidizing devices,” filed Nov. 28, 2022. |
Gomes et al.; U.S. Appl. No. 18/044,027 entitled “Dynamically rigidizing guiderail and methods of use,” filed Mar. 3, 2023. |
Tilson et al.; U.S. Appl. No. 18/325,974 entitled “Endscope sheath apparatuses,” filed May 30, 2023. |
Tilson et al.; U.S. Appl. No. 18/325,979 entitled “Apparatuses and methods for determining if an endscope is contaminated,” filed May 30, 2023. |
Tilson et al.; U.S. Appl. No. 18/325,990 entitled “Multi-lumen port adapter mainfold devices and methods of use,” filed May 30, 2023. |
Gomes et al.; U.S. Appl. No. 18/263,517 entitled “Devices and methods to prevent inadvertent motion of dynamically rigidizing apparatuses,” filed Jul. 28, 2023. |
Lopez et al.; U.S. Appl. No. 18/334,555 entitled “Layered walls for rididizing devices,” filed Jun. 14, 2023. |
Tilson et al.; U.S. Appl. No. 18/262,904 entitled “Large diameter hemostasis valves,” filed Jul. 25, 2023. |
Bearing Works; PTFE Datasheet; 2 pages; Jan. 21, 2021 retrieved from the internet (https://www.bearingworks.com/uploaded-assets/pdfs/retainers/ptfe-datasheet.pdf) on Nov. 10, 2023. |
Number | Date | Country | |
---|---|---|---|
20220000355 A1 | Jan 2022 | US |
Number | Date | Country | |
---|---|---|---|
62376816 | Aug 2016 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16325497 | US | |
Child | 17448188 | US |